Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Inogen and Abiomed Are Struggling in 2019


Inogen (NASDAQ: INGN) and Abiomed (NASDAQ: ABMD) are innovative medical device companies that have put up impressive growth numbers in recent years. However, they both failed to meet Wall Street's expectations for their second-quarter earnings results and cut full-year guidance in response.

In this segment from Industry Focus: Healthcare, host Shannon Jones and Fool.com contributor Brian Feroldi dig into these businesses' quarterly numbers and discuss whether they can get their growth engines back on track.

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. A full transcript follows the video.

Continue reading


Source Fool.com

Like: 0
Share

Comments